[1]Patent:EP1186604,2002,A1.Locationinpatent:Page132
[1]Patent:US6204293,2001,B1
[1]Patent:EP1186604,2002,A1
[1]Patent:US2014/107094,2014,A1.Locationinpatent:Paragraph0617;0618
[2]Patent:US2014/107097,2014,A1.Locationinpatent:Paragraph0400;0401
[3]Patent:US2015/105404,2015,A1.Locationinpatent:Paragraph0279
[4]Patent:US2015/105366,2015,A1.Locationinpatent:Paragraph0316;0317
[5]Patent:WO2015/57205,2015,A1.Locationinpatent:Page/Pagecolumn92
[6]Patent:WO2015/57203,2015,A1.Locationinpatent:Page/Pagecolumn72
[7]Patent:US2015/111870,2015,A1.Locationinpatent:Paragraph0371;0372
[1]Dang,Xin;Lei,Shuwen;Luo,Shuhua;Hu,Yixin;Wang,Juntao;Zhang,Dongdong;Lu,Dan;Jiang,Faqin;Fu,Lei[BioorganicChemistry,2021,vol.114]
Title: 5-(4-Chloro-phen-yl)-3-(2,4-dimethyl-thiazol-5-yl)-1,2,4-triazolo[3,4-a]isoquinoline.
Journal: Acta crystallographica. Section E, Structure reports online 20100501